within Pharmacolibrary.Drugs.ATC.G;

model G04BD10
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.19,
    Cl             = 0.0006666666666666666,
    adminDuration  = 600,
    adminMass      = 15 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.163,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.002,
    Tlag           = 720,            
    Vdp             = 0.353,
    k12             = 43,
    k21             = 43
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G04BD10</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Darifenacin is a selective muscarinic M3 receptor antagonist used to treat symptoms of overactive bladder, such as urinary incontinence, urgency, and frequency. It is approved for clinical use and is commonly administered orally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers after repeated oral administration.</p><h4>References</h4><ol><li><p>Skerjanec, A (2006). The clinical pharmacokinetics of darifenacin. <i>Clinical pharmacokinetics</i> 45(4) 325–350. DOI:<a href=\"https://doi.org/10.2165/00003088-200645040-00001\">10.2165/00003088-200645040-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16584282/\">https://pubmed.ncbi.nlm.nih.gov/16584282</a></p></li><li><p>Ishaq, W, et al., &amp; Safdar, Z (2024). Design and Evaluation of Inorganic/Organic Hybrid Bio-composite for Site-Specific Oral Delivery of Darifenacin. <i>AAPS PharmSciTech</i> 25(7) 204–None. DOI:<a href=\"https://doi.org/10.1208/s12249-024-02916-5\">10.1208/s12249-024-02916-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39237789/\">https://pubmed.ncbi.nlm.nih.gov/39237789</a></p></li><li><p>Croom, KF, &amp; Keating, GM (2004). Darifenacin: in the treatment of overactive bladder. <i>Drugs &amp; aging</i> 21(13) 885–894. DOI:<a href=\"https://doi.org/10.2165/00002512-200421130-00005\">10.2165/00002512-200421130-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15493952/\">https://pubmed.ncbi.nlm.nih.gov/15493952</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G04BD10;
